
Ashok Bhatia
About Ashok Bhatia
Data last updated:
Ashok Bhatia has 18 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Liva Healthcare Limited and Onnext Healthcare Private Limited. Formerly with 4 companies, such as Alidac Pharmaceuticals Limited and Santis Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Designated Partner | 10 Feb 2017 | 2017 | Active | |
| Director | 23 Oct 2017 | 2004 | Active | |
| Director | 01 Apr 2025 | 1984 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Additional Director | 15 Mar 2008 | 2005 | Amalgamated | |
| Director | 07 Feb 2020 | 2010 | Active | |
| Director | 03 Dec 2012 | 1982 | Amalgamated | |
| Director | 17 Mar 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Bhatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Bhatia
Ashok Bhatia has 18 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Liva Healthcare Limited and Onnext Healthcare Private Limited. Formerly with 4 companies, such as Alidac Pharmaceuticals Limited and Santis Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Ashok Bhatia is associated with 3 companies as Director and Designated Partner.
Ashok Bhatia has expertise in Healthcare, General Business.
Ashok Bhatia has 18 years in corporate governance.